These were more likely to show concomitant cardiovascular and cerebrovascular disease, wheeze (63.2 % vs. 11.4 %), and an increased level of carcinoembryonic antigen (CEA) as compared to patients in the IPF group (P < 0.05). The gene discussed is CEACAM5; the disease is cerebrovascular disorder.